PRACOH Prevention Breakdown Support Advice Guidance Disability
France100 participantsStarted 2026-04
Plain-language summary
The main objective of this prospective interventional study is to evaluate the impact of the stay in the dedicated transitional care unit, through the achievement of the patient's primary objective set at admission, directly related to their specific needs.
It is expected to improve knowledge regarding the prevention of situations of breakdown and exhaustion in the living environment of people with disabilities.
* This would improve the life and care pathways as well as the support provided to these individuals and their families and friends.
* It would limit the use of unscheduled care services in crisis situations, thereby improving the quality of care and life.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients:
* People with disabilities requiring a 4-week stay in a dedicated transitional care unit at POLE MPR ST HELIER
* Men or women, of legal age (over 18)
* Affiliated with a social security scheme or entitled to benefits
* Having given their free and informed consent
* Caregivers:
* Primary caregiver from the circle of a person with a disability who has agreed to participate in the study.
* Male or female, of legal age (over 18)
* Affiliated with a social security scheme or entitled to benefits
* Having given their free and informed consent
Exclusion Criteria:
* Patients:
* Pregnant women, women in labor, or women who are breastfeeding
* Individuals deprived of their liberty by judicial (excluding guardianship or curatorship) or administrative decision
* Individuals undergoing severe psychiatric treatment that may impact the conduct of the protocol, at the investigator's discretion
* Individuals in an emergency situation who are unable to give their prior consent.
* Individuals already admitted to a healthcare or social care facility for purposes other than research.
* Caregivers:
* Professional caregivers of participants with disabilities who have agreed to participate in the study.
* Pregnant women, women in labor, or women who are breastfeeding,
* Individuals deprived of their liberty by a judicial (excluding guardianship or curatorship) or administrative decision.
* Individuals undergoing severe psychiat…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
The main objective of this prospective interventional study is to evaluate the impact of the stay in the dedicated transitional care unit, through the achievement of the patient's main objective set at admission, directly related to their specific needs.